Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mangosteen Peel as Medicine - CU's Faculty of Veterinary Science is Successful in Replicating Mangosteen Peel Extract, Treatment for Intestinal Inflammation in Humans and Animals 2022-08-24 10:00
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study 2022-08-24 09:00
Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) in Patients with Advanced Malignancies 2022-08-24 08:00
Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results 2022-08-24 07:30
Targeted Alpha Therapy Candidate: Bladder Cancer Study Completes Enrolment 2022-08-24 05:56
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals 2022-08-23 17:58
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program 2022-08-23 14:15
Announcement of 2022 Future Science Prize Winners: Wenhui Li, Xueming Yang, Ngaiming Mok 2022-08-23 11:52
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head 2022-08-23 07:30
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc. 2022-08-22 18:00
The 2022 Smart China Expo kicked off, smart technology empowers Chongqing Liangjiang New Area to lead innovative development 2022-08-22 15:37
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 2022-08-22 10:05
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes 2022-08-22 08:33
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA 2022-08-22 08:10
Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-19 18:15
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ 2022-08-19 13:31
Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines 2022-08-19 11:29
Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma 2022-08-18 21:35
Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader 2022-08-18 15:25
Innovent Announces First Subject Dosed in Phase 1 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) 2022-08-18 08:00
1 65 66 67 68 69 230